Pantomed (Pantoprazole)

Pantoprazole, the active ingredient in Pantomed, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It suppresses gastric acid secretion and is employed in the treatment and prevention of acid‑related disorders such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and stress‑related gastric ulcers.

GNH USA supplies Pantomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Pantomed (pantoprazole) is indicated for several acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): reduces gastric acid exposure, relieving heartburn and regurgitation. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Peptic ulcer disease: facilitates ulcer closure by maintaining a higher gastric pH. - Stress ulcer prophylaxis: prevents development of gastric ulcers in critically ill or postoperative patients.

Pantomed may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring during treatment. - Nausea: transient feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Injection site reactions: erythema or mild pain at the IV site.

Serious or Rare Side Effects: - Severe hypersensitivity: rash, pruritus, angioedema, or anaphylaxis. - Clostridioides difficile infection: persistent diarrhea with possible colitis. - Electrolyte disturbances: hypomagnesemia or hypocalcemia. - Hepatic dysfunction: elevated transaminases or jaundice. - Acute interstitial nephritis: renal impairment with fever and eosinophilia.

Before initiating Pantomed therapy, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be required in severe impairment. - Review concomitant medications: avoid co‑administration with drugs that require gastric acidity for absorption. - Monitor for infection: prolonged acid suppression can increase risk of gastrointestinal infections. - Evaluate liver status: use caution in patients with hepatic impairment. - Pregnancy and lactation: limited data; prescribe only if benefit outweighs potential risk. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Pantomed can interact with other medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption due to increased gastric pH. - HIV protease inhibitors (e.g., atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: reduced antiplatelet effect when combined with pantoprazole.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation parameters. - Methotrexate: higher serum levels may occur, especially in renal impairment. - Digoxin: slight increase in serum concentration, monitor for toxicity.